Literature DB >> 8083824

Mode of delivery and vertical transmission of HIV-1: a review of prospective studies. Perinatal AIDS Collaborative Transmission Studies.

D T Dunn1, M L Newell, M J Mayaux, C Kind, C Hutto, J J Goedert, W Andiman.   

Abstract

Entities:  

Mesh:

Year:  1994        PMID: 8083824

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr (1988)        ISSN: 0894-9255


× No keyword cloud information.
  8 in total

1.  Human immunodeficiency virus infection in pregnancy.

Authors:  Y Arikan; D R Burdge
Journal:  Can J Infect Dis       Date:  1998-09

2.  The maternal and child health sites' practices regarding HIV education, counseling, and testing of women of reproductive age in Chicago: barriers to universal implementation.

Authors:  A Rahimian; M Driscoll; D Taylor
Journal:  Matern Child Health J       Date:  1998-03

Review 3.  Economic issues in the prevention of vertical transmission of HIV.

Authors:  A E Ades; J Ratcliffe; D M Gibb; M J Sculpher
Journal:  Pharmacoeconomics       Date:  2000-07       Impact factor: 4.981

4.  Prevention of vertical transmission of HIV: analysis of cost effectiveness of options available in South Africa.

Authors:  N Söderlund; K Zwi; A Kinghorn; G Gray
Journal:  BMJ       Date:  1999-06-19

Review 5.  A risk-benefit assessment of zidovudine in the prevention of perinatal HIV transmission.

Authors:  M L Newell; D M Gibb
Journal:  Drug Saf       Date:  1995-04       Impact factor: 5.606

6.  Mother-to-child transmission of human immunodeficiency virus type 1: influence of parity and mode of delivery. Paediatric AIDS Group of Switzerland.

Authors:  C Kind
Journal:  Eur J Pediatr       Date:  1995-07       Impact factor: 3.183

Review 7.  Prevention and control of HIV/AIDS.

Authors:  Madhu Choudhry; V P Choudhry
Journal:  Indian J Pediatr       Date:  2003-12       Impact factor: 1.967

8.  Host factors that influence mother-to-child transmission of HIV-1: genetics, coinfections, behavior and nutrition.

Authors:  Sascha R Ellington; Caroline C King; Athena P Kourtis
Journal:  Future Virol       Date:  2011-11-24       Impact factor: 1.831

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.